Cresco Labs Reports Q4 and Fiscal Year 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its fourth-quarter and full-year 2025 earnings, showing revenue of $162 million for the final three months and a focus on cash flow amid industry pressures. The company generated $656 million in total revenue for the year, down from prior periods but with stronger profitability measures in some areas.

In the fourth quarter, adjusted gross profit reached $84 million, reflecting a 52.2% margin, up sequentially from earlier quarters. Adjusted EBITDA came in at $40 million, or 25% of revenue, while operating cash flow stood at $27 million. However, the period included a net loss of $89 million, driven largely by $93 million in non-cash charges tied to a write-down of its New York operations. Selling, general, and administrative expenses totaled $57 million, or 35.3% of revenue.

For the full year, adjusted gross profit was $329 million at a 50.2% margin, with adjusted EBITDA of $157 million, or 24% of revenue. Operating cash flow hit $73 million, and free cash flow was $38 million. The annual net loss widened to $140 million, influenced by $105 million in non-cash impairments related to New York and adjustments from the sale of a California unit. Adjusted SG&A expenses dropped 5.7% year-over-year to $200 million, or 30.4% of revenue.

Operationally, Cresco held top market share in several large states, emphasizing brand strength and retail performance. Chief Executive Charles Bachtell said in a statement that the results reflect a strategy aimed at building a cash-focused platform through organic growth and targeted buys, positioning the company to benefit from market shifts. “We continue to show that we win where we operate,” Bachtell noted.

Cresco’s top-line performance reflects persistent headwinds in the sector, such as declining prices and surplus inventory across established markets, leading to a year-over-year drop that mirrors trends seen among many MSOs. However, the uptick in gross margins signals effective cost management and operational tweaks, bringing the company in line with industry benchmarks for similar firms while outperforming its own historical figures slightly.

EBITDA margins also strengthened, remaining on par with competitors like Curaleaf in recent quarters but trailing behind higher-scale players such as Trulieve, which benefit from greater volume to sustain superior profitability.

The shift toward positive cash generation highlights a commitment to efficiency and debt trimming, with administrative costs shrinking as a share of sales – a clear indicator of restraint in a low-growth environment. When stacked against bigger peers like Green Thumb Industries, Cresco’s more compact operations result in scaled-back earnings but showcase durability through sustained cash inflows, an uncommon feat in a field riddled with ongoing capital drains.

Looking ahead, eased national regulations or new recreational rollouts in key areas like Florida and Pennsylvania might amplify its stronghold in core territories, yet persistent write-downs on lagging assets underscore vulnerabilities in portfolio optimization. In sum, these dynamics frame Cresco as an agile contender ready for incremental advances within a consolidating industry.